...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM thoughts

Good question about whether the financing is ZCC or ZEL. Yes, I have sent questions in advance of Resverlogix corporate updates or AGMs before. I will do again for Resverlogix and Zenith no later than end of week.

BDAZ

Share
New Message
Please login to post a reply